Brought to you by 
TranS1 nets $86.2mm via IPO
10 Jan 2008
Executive Summary
TranS1 (developing minimally invasive procedures to treat lower back pain) has netted $86.2mm (including the overallotment) in its initial public offering of 6.325mm shares priced at $15 each, better than the $12-14 price estimate the company announced in September.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com